Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone adjunctive maintenance treatment in bipolar I disorder
2011-000986-10Phase 3Completed
- Sponsor
- Sunovion
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder and bipolar disorder (BD) comparing Lurasidone + lithium/divalproex with Placebo + lithium/divalproex (2 arms). Primary endpoint: Time to recurrence of any mood event. Started Aug 2011; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2011-000986-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000986-10.